eli lilly glp-1 drugs The FDA approved a new pill from on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication The Medicine Maker | Insights

Incidence of alopecia areata in Olmstead County, Minnesota, 1975 through 1989

Gut health issues: Digestive improvements often appear within 12 weeks, with optimal results after 46 weeks of treatment

Key Feature: BRAIN & MUSCLE SUPPORT:Swanson's Acetyl-L-Carnitine supplement is formulated to help support muscle health and cognitive function

Effect on cardiac ischemia and cardiac outcomes L-carnitines theoretical benefit in improving clinical outcomes, particularly after ischemic events and cardiac surgeries, is well-established

This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)